从预测到证据：COVID-19 大流行期间精神分裂症患者的治疗依从性、疾病进展和社会依从性。
From predictions to evidence: Treatment compliance, disease progression and social compliance of patients with schizophrenia in the COVID-19 pandemic.
机构信息
Department of Psychiatry, Ankara City Hospital, University of Health Sciences, Ankara, Bilkent, Turkey.
出版信息
Perspect Psychiatr Care. 2021 Oct;57(4):1991-1998. doi: 10.1111/ppc.12824. Epub 2021 May 3.
Abstract
PURPOSE
This study explored how patients with schizophrenia were provided with social support and treatment compliance during the pandemic.
DESIGN AND METHODS
A total of 396 patients with schizophrenia and their relatives were interviewed by telephone calls.
FINDINGS
Multiple antipsychotic use and depot antipsychotics were not superior in preventing relapse. A total of 70.2% of the patients wanted to meet with their psychiatrist online but only 7.1% of them were reached online. A total of 59% of patients were able to take their medication thanks to the extension of their drug prescriptions.
PRACTICE IMPLICATIONS
Active inclusion of telepsychiatry applications in clinical practice is necessary for patients with schizophrenia. Government policies developed for treatment compliance seem important.
摘要
目的
本研究探讨了在疫情期间，精神分裂症患者如何获得社会支持和治疗依从性。
设计和方法
通过电话访谈的方式，共对 396 名精神分裂症患者及其家属进行了采访。
结果
多种抗精神病药物联合使用和长效抗精神病药物并不能更好地预防复发。共有 70.2%的患者希望与精神科医生进行在线会诊，但只有 7.1%的患者能够进行在线会诊。由于延长了药物处方，共有 59%的患者能够服药。
实践意义
为精神分裂症患者积极纳入远程精神病学应用于临床实践是必要的。为提高治疗依从性而制定的政府政策似乎很重要。
相似文献
1
From predictions to evidence: Treatment compliance, disease progression and social compliance of patients with schizophrenia in the COVID-19 pandemic.从预测到证据：COVID-19 大流行期间精神分裂症患者的治疗依从性、疾病进展和社会依从性。
Perspect Psychiatr Care. 2021 Oct;57(4):1991-1998. doi: 10.1111/ppc.12824. Epub 2021 May 3.
3
Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.致编辑的信：COVID-19 大流行对精神分裂症患者的影响。
Turk Psikiyatri Derg. 2021 Fall;32(3):219-221. doi: 10.5080/u26175.
4
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].[精神分裂症患者护理环境的成本效益分析：长效注射制剂下非典型抗精神病药物的影响]
Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5.
5
Management of psychiatric treatments of patients diagnosed with bipolar disorder in the COVID-19 pandemic: A one-year evaluation in the pandemic.COVID-19 大流行期间双相障碍患者精神科治疗的管理：大流行期间的一年评估。
Chronic Illn. 2024 Mar;20(1):49-63. doi: 10.1177/17423953231156783. Epub 2023 Feb 12.
6
Long acting injectable antipsychotics: Uninterrupted use during the COVID-19 pandemic.长效注射用抗精神病药物：在新冠疫情期间持续使用
J Psychiatr Ment Health Nurs. 2022 Feb;29(1):169-170. doi: 10.1111/jpm.12750. Epub 2021 Mar 10.
7
Assessment of compliance and relapse in patients with schizophrenia before and after the onset of COVID-19 pandemic.评估 COVID-19 大流行前后精神分裂症患者的依从性和复发情况。
Int J Psychiatry Clin Pract. 2023 Jun;27(2):127-133. doi: 10.1080/13651501.2022.2124175. Epub 2022 Sep 23.
8
[If drugs are not taken - how different antipsychotics influence compliance of schizophrenic patients].[若不服用药物——不同抗精神病药物如何影响精神分裂症患者的依从性]
Fortschr Neurol Psychiatr. 2007 Aug;75(8):473-7. doi: 10.1055/s-2007-980067.
9
To tele- or not to telehealth? Ongoing COVID-19 challenges for private psychiatry in Australia.是否采用远程医疗？澳大利亚私立精神病学面临的持续新冠疫情挑战。
Australas Psychiatry. 2020 Oct;28(5):511-513. doi: 10.1177/1039856220950081. Epub 2020 Aug 26.
10
Telepsychiatry during the COVID-19 pandemic: An experience in a low resource setting.COVID-19大流行期间的远程精神病学：资源匮乏地区的经验
Asian J Psychiatr. 2022 Mar;69:103000. doi: 10.1016/j.ajp.2021.103000. Epub 2021 Dec 29.
引用本文的文献
1
Changes in Antipsychotic Medication Adherence Among Medicaid Beneficiaries with Schizophrenia During COVID-19.新冠疫情期间医疗补助计划中患有精神分裂症的受益人群抗精神病药物依从性的变化
Adm Policy Ment Health. 2025 Mar;52(2):277-284. doi: 10.1007/s10488-024-01416-9. Epub 2024 Oct 11.
2
Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic.2019年冠状病毒病大流行期间，使用长效注射用抗精神病药物（LAIs）治疗的精神分裂症患者临床管理的变化，包括远程精神病学的应用。
Neuropsychiatr Dis Treat. 2023 Mar 17;19:623-634. doi: 10.2147/NDT.S394220. eCollection 2023.
3
Adherence to treatment of children and adolescents recently diagnosed with auto-immune Rheumatic Diseases during the COVID-19 pandemic.COVID-19 大流行期间最近被诊断为自身免疫性风湿病的儿童和青少年的治疗依从性。
J Pediatr (Rio J). 2023 May-Jun;99(3):289-295. doi: 10.1016/j.jped.2022.11.014. Epub 2023 Jan 27.
4
The effect of the COVID-19 pandemic on health behavior and psychopathology in patients with psychotic disorders.COVID-19 大流行对精神病患者健康行为和精神病理学的影响。
Psychiatry Res. 2022 Nov;317:114845. doi: 10.1016/j.psychres.2022.114845. Epub 2022 Sep 13.
5
Medication Adherence and Belief about Medication among Vietnamese Patients with Chronic Cardiovascular Diseases within the Context of Implementing Measures to Prevent COVID-19.在实施预防新冠疫情措施背景下越南慢性心血管疾病患者的药物依从性及对药物的认知
J Cardiovasc Dev Dis. 2022 Jun 26;9(7):202. doi: 10.3390/jcdd9070202.
6
Medication Adherence of Vietnamese Outpatients with Chronic Diseases during the COVID-19 Pandemic.新冠疫情期间越南慢性病门诊患者的用药依从性
Trop Med Infect Dis. 2022 Jun 13;7(6):101. doi: 10.3390/tropicalmed7060101.
7
Changes in the Mean of Medical Visits Due to Psychiatric Disease in Korean Children and Adolescents before and during the COVID-19 Pandemic.韩国儿童和青少年在新冠疫情之前及期间因精神疾病进行医疗就诊的均值变化
Life (Basel). 2022 Apr 18;12(4):600. doi: 10.3390/life12040600.
本文引用的文献
1
Anxiety and hopelessness levels in COVID-19 pandemic: A comparative study of healthcare professionals and other community sample in Turkey.COVID-19 大流行期间的焦虑和绝望水平：土耳其医护人员和其他社区样本的对比研究。
J Psychiatr Res. 2020 Oct;129:181-188. doi: 10.1016/j.jpsychires.2020.07.024. Epub 2020 Jul 21.
2
Telepsychiatry and healthcare access inequities during the COVID-19 pandemic.新冠疫情期间的远程精神病学与医疗服务可及性不平等问题
Asian J Psychiatr. 2020 Oct;53:102234. doi: 10.1016/j.ajp.2020.102234. Epub 2020 Jun 16.
3
Long-acting injectable antipsychotics treatment during COVID-19 pandemic - A new challenge.2019冠状病毒病大流行期间长效注射用抗精神病药物治疗——一项新挑战。
Schizophr Res. 2020 Jun;220:265-266. doi: 10.1016/j.schres.2020.04.030. Epub 2020 Apr 27.
4
The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders.《COVID-19 全球大流行：对精神分裂症及相关障碍患者的影响》。
Schizophr Bull. 2020 Jul 8;46(4):752-757. doi: 10.1093/schbul/sbaa051.
5
Multiple antipsychotics use in patients with schizophrenia: Why do we use it, what are the results from patient follow-ups?精神分裂症患者使用多种抗精神病药物：我们为何使用，患者随访结果如何？
Asian J Psychiatr. 2020 Aug;52:102063. doi: 10.1016/j.ajp.2020.102063. Epub 2020 Apr 9.
6
COVID-19 and mental health: A review of the existing literature.新型冠状病毒肺炎（COVID-19）与心理健康：现有文献综述。
Asian J Psychiatr. 2020 Aug;52:102066. doi: 10.1016/j.ajp.2020.102066. Epub 2020 Apr 10.
7
Mental health problems and social media exposure during COVID-19 outbreak.新冠疫情期间的心理健康问题与社交媒体暴露
PLoS One. 2020 Apr 16;15(4):e0231924. doi: 10.1371/journal.pone.0231924. eCollection 2020.
8
Schizophrenia and COVID-19: risks and recommendations.精神分裂症与2019冠状病毒病：风险与建议
Braz J Psychiatry. 2020;42(3):236-238. doi: 10.1590/1516-4446-2020-0010. Epub 2020 Apr 9.
9
The consequences of the COVID-19 pandemic on mental health and implications for clinical practice.2019冠状病毒病大流行对心理健康的影响及其对临床实践的启示。
Eur Psychiatry. 2020 Apr 1;63(1):e32. doi: 10.1192/j.eurpsy.2020.35.
10
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
Zotero 插件